Ellen Snow

Ellen Snow discloses dealings in 3 companies, chiefly Akebia Therapeutics, Inc., Pear Therapeutics, Inc. and AlerisLife Inc. In total, 5 filings cover trades dated from 14 December 2020 to 31 January 2024.

No open-market purchase appears, only 1 sale worth €8,372. The rest of the record consists of 3 share grants and 1 option exercise.

The latest filing, published on 2 February 2024, reports a share grant in Akebia Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.